Status:
COMPLETED
Improving HIV/Tuberculosis Outcomes in Irkutsk
Lead Sponsor:
University of Virginia
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Scientific Center for Family Health and Human Reproduction Problems, Russia
Conditions:
Tuberculosis
HIV Infections
Eligibility:
All Genders
18-64 years
Brief Summary
The investigators propose to examine the prospective influence of substance use patterns on HIV/tuberculosis adherence, pharmacokinetics and disease progression while developing novel methods for earl...
Detailed Description
Subjects will be recruited at the Irkutsk Clinical Tuberculosis Hospital by trained research staff. Potential subjects are frequently diagnosed with HIV during their presentation with tuberculosis (TB...
Eligibility Criteria
Inclusion
- Adults 18-64 years of age
- HIV infected (confirmed by medical chart review)
- Initiating TB treatment (with anti-TB medicine)
- Initiating HIV treatment (with antiretroviral medicine)
- History of any substance use (confirmed by medical chart review)
- Primary residence in Irkutsk City, Russian Federation
Exclusion
- Unable or unwilling to operate a smartphone
- Pregnant at time of enrollment per lab results (urine or serum) from Medical Record
- Prisoners Cognitively unable to provide informed consent
Key Trial Info
Start Date :
April 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT03819374
Start Date
April 15 2018
End Date
April 30 2021
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irkutsk Regional Clinical Tuberculosis Hospital
Irkutsk, Russia